A Phase 1, Double‐Blind, Placebo‐Controlled Trial of Sevasemten (<scp>EDG</scp>‐5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy

Authors

Institutions

Publication Details

Journal
Muscle & Nerve
Published
2025-06-02
DOI
https://doi.org/10.1002/mus.28444
Citations
2
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase 1, Double‐Blind, Placebo‐Controlled Trial of Sevasemten (EDG‐5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy

Gilad Gordon, Jeffrey A. Silverman, Ben Barthel, Marc Evanchik et al.
2 citations
Muscle & Nerve
Muscle Physiology and Disorders
1.61
article

A Phase 1, Double‐Blind, Placebo‐Controlled Trial of Sevasemten (EDG‐5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy

Gilad Gordon, Jeffrey A. Silverman, Ben Barthel, Marc Evanchik, James E. MacDougall, Kevin M. Koch, Molly Madden, Michael DuVall, Abby Bronson, Nicole Kilburn, Alan J. Russell, Joanne M. Donovan
article en
2 citations

Abstract

No abstract available for this paper.
Muscle & NerveVol. 72(3)
Nivalis Therapeutics (United States) (US)
Good health and well-being
Openalex Percentile: Top 17%
Muscle Physiology and Disorders
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.